Imara
expected near term clinical milestones for parallel lead product candidates | Imara
Company
Deck Type
Deck date
October 2022
Slide
17 of 45
Related slides by other companies
ATAI
Investor Presentation
October 2023
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
ATAI
Investor Presentation
January 2024
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
Chimerix
Investor Presentation
August 2023
agonist distinct molecular target and efficacy profile relative to efficacy in preclinical models of advanced cancers tox studies complete potential to advance to partnerships established for early stage clinical trials with brown university and cancer center preclinical studies are ongoing to evaluate additional oncology indications and predictive for for clinical development pancreatic cancer model shows the potential of | Chimerix
argenx SE
Results
February 2024
this is just the beginning fret tree terete tartar tree tara a a | argenx SE
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io